Mount Sinai Medical Center closed its 75th anniversary year with key gains across expansion and capital improvement projects, clinical programs, and digital infrastructure, reinforcing its role as a leading healthcare provider for South Florida. The system’s 2025 initiatives focused on expanding access, strengthening specialty care and improving outcomes for patients across Miami-Dade and Monroe counties.
Oncology Expansion and Major Capital Progress
Construction progresses on the Braman Comprehensive Cancer Center, set to open in mid-2026. The facility will centralize medical, surgical and radiation oncology with diagnostics, clinical research and supportive services, reducing fragmentation and improving coordination for patients navigating complex treatment pathways.
The gynecologic oncology program, led by Dr. Brian Slomovitz, broadened its portfolio of clinical trials and now offers more gynecologic cancer studies than any other center in South Florida. The program contributed to research that supported the first FDA-approved treatment for KRAS-mutated low-grade serous ovarian cancer, expanding therapeutic options for a subset of patients with limited alternatives.
Expanding Access Across Miami-Dade and Monroe Counties
Mount Sinai advanced several market expansion projects aimed at improving reach in high-growth areas.
The Westchester freestanding emergency center will open in late 2026 with 26 bays, advanced imaging and a Baker Act receiving unit. This marks the first phase of a multi-year plan to develop the organization’s second hospital in Miami-Dade County, adding inpatient beds, procedural capacity and a future medical office building.
In East Hialeah, a new 33,000-square-foot site opened in July, brought primary care, urology and cardiology to a densely populated area with rising demand for outpatient services. The location will continue to expand the services offered in 2026.
In April, a new Key West location opened to provide primary care, walk-in care and on-site diagnostics, offering residents and seasonal visitors closer access to essential services.
Strategic Growth in Cardiovascular and Thoracic Care
As the number one cardiovascular program in South Florida for both outcomes and volume, the medical center continued to invest by building on existing expertise, recruiting subspecialists and supporting research that moves complex care forward. The arrival of Dr. Eric Weiss as President of Cardiovascular and Thoracic Surgery and Co-Director of Valve Surgery added further depth to a high-acuity service line that supports patients with complex valve disease.
Mount Sinai advanced its research footprint through a study led by interventional cardiologist Dr. Nirat Beohar, evaluating an FDA-approved device intended to help reduce stroke and cognitive decline following cardiac surgery. As the first center to introduce the protocol, Mount Sinai provided early access for local patients and strengthened its position in trial-based innovation.
Thoracic surgery continued to serve as a regional referral destination. The program became the first in Florida to use real-time hybrid OR imaging for early-stage lung cancer, supporting improved accuracy in diagnosis and treatment. The team reports a five-year survival rate of 83% for stage one lung cancer, well above national figures—a meaningful advantage for patients facing a time-sensitive disease.
Quality, Digital Advancement and Workforce Support
Mount Sinai earned national recognition from Healthgrades as one of America’s 100 Best Hospitals, along with multiple specialty distinctions across cardiac, neurosciences, pulmonary and gastrointestinal care. NRC Health honored the system for patient experience, and the American Heart Association acknowledged the organization’s stroke performance through multiple Get With The Guidelines® distinctions.
The medical center reached HIMSS EMRAM Stage 7, reflecting a highly integrated digital environment that supports safety, communication and care coordination across sites.
Looking Ahead
As Mount Sinai moves into 2026, the system remains focused on expanding access, strengthening high-demand service lines and building capacity to meet the needs of a growing region. The momentum from 2025 positions the organization to support patients and communities with the scale, expertise and infrastructure required for the years ahead.
